Healios K.K.
Quick facts
Phase 3 pipeline
- MultiStem® · Immunology, Regenerative Medicine
MultiStem is a cell therapy derived from bone marrow-derived mesenchymal stem cells that modulates immune responses and promotes tissue repair.
Phase 2 pipeline
- HLCM051 · Diabetes
HLCM051 is a small molecule targeting the SGLT2 receptor.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: